Compare Amphastar Pharmaceuticals Inc (AMPH) vs First Trust NASDAQ Cybersecurity ETF (CIBR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs First Trust NASDAQ Cybersecurity ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $25.98 (market cap $1.14B), while First Trust NASDAQ Cybersecurity ETF trades at $103.22 (market cap $16.90B). The key difference: First Trust NASDAQ Cybersecurity ETF is far larger — about 14.8× Amphastar Pharmaceuticals Inc's market cap, and First Trust NASDAQ Cybersecurity ETF is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Amphastar Pharmaceuticals Inc for 16 Days and First Trust NASDAQ Cybersecurity ETF for 116 Days on average.
| AMPH | CIBR | |
|---|---|---|
Market Cap | $1.14B | $16.90B |
Volume | 626,940 | 1,784,150 |
Sector | Health | — |
52-Week High | $29.40 | $104.01 |
52-Week Low | $16.87 | $60.74 |
Typical Hold Time | 16 Days | 116 Days |
Enterprise Value | $1.53B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $25.81, down 5.77% today, with mixed technical signals showing bullish moving averages but overbought RSI levels. The company reported Q2 2026 EPS of $0.91, beating expectations by 47%, though recent quarters showed misses. Revenue growth remains stable at $730M projected for 2026, while net income margin compressed to 10.76%. Recent news includes insider selling and participation in healthcare conferences.
Outlook remains cautious with analyst consensus at Hold (66.7%) and price target of $21.25 below current levels. Opportunities include product launches and pipeline investments, while risks involve FDA warning letters, tariff impacts on generics, and earnings volatility. The stock faces headwinds from mixed sentiment and valuation concerns.
CIBR trades at $103.09, up 1.4% today, with a bullish technical signal driven by moving averages. The ETF benefits from strong cybersecurity demand amid AI-driven threats, though valuations of top holdings like CrowdStrike and Palo Alto Networks are stretched. Recent news highlights sector momentum, with earnings beats and institutional activity supporting interest.
Outlook is positive due to cybersecurity's critical role in AI adoption, but risks include high valuations and potential sector rotation. Investors may see growth from rising cyber spending, yet volatility from tech shifts warrants caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About First Trust NASDAQ Cybersecurity ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as cyber security companies. The fund is non-diversified.
Read more on CIBR →
